Bayer
Bayer boosted by Schering integration
March 4, 2009Sales and Marketing Bayer
Profits at Bayer's healthcare division rose by 10% to 4.1 billion euros last year as it increasingly felt the benefits …
Chinese move marks ‘globalisation’ of Bayer Schering R&D
March 2, 2009Research and Development Asia, Bayer, China
Bayer Schering Pharma's plan to build a 100 million-euro R&D centre in Beijing marks the company's first major foray into …
Bayer’s cardiovascular drug enters phase III
February 13, 2009Research and Development, Sales and Marketing Bayer, cv
Bayer Schering Pharma has begun phase III trials of riociguat for treatment of two life-threatening conditions. Two trials will investigate …
Contraceptive and Betaferon sales bolster Bayer
October 30, 2008Sales and Marketing Bayer
Strong sales of Bayer's Yaz contraceptives and multiple sclerosis treatment Betaferon have helped third quarter pharma sales that could only …
The Pharmafocus Interview: Martin Dawkins
September 4, 2008Research and Development, Sales and Marketing Bayer, Cancer, NICE, Xarelto, healthcare
Martin Dawkins is an Englishman born and bred, but has spent most of his career working abroad, including the US, …
Bayer Schering blood clotting drug a ‘major leap forward’
December 14, 2007Sales and Marketing Bayer, Xarelto, clot
Bayer Schering says its new blood clotting drug Xarelto is poised to set a new standard of care for post-surgery …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
